entertainment -WSS

entertainment

author：knowledge 2025-08-23 08:57:03 - browse：1874

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

WSS

Making the case for fair compensation in clinical trials

Harvard scientists, with Google, unveil the most detailed brain map ever

Addressing health care workers' trauma can help fight burnout

Medicare Advantage 2025 payments will dip, Biden administration says

Bird flu in dairy cattle: New measures to control spread to humans

Addressing health care workers' trauma can help fight burnout

leisure time

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Affirmative action in medical school literally saved lives

Eyeing GLP

ChatGPT in medicine: STAT answers readers' burning questions

Making the case for fair compensation in clinical trials

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Study finds gene variants tied to breast cancer risk in Black women

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

hotspot

Trial using CRISPR to edit HIV out of cells disappoints

Bird flu surveillance in wastewater gets boost from consortium

Insurer loopholes limit power of law against surprise medical bills

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Investigation reveals sickle cell patients pressured into sterilizations

Pancreatic cancer is often deadly, but new discoveries are raising hope

Wikipedia

focus

leisure time

focus